From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.

The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.

offering fresh hope for those struggling with recurrent and drug-resistant UTIs. Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3 ...

Researchers say they have discovered a new class of antibiotics that could treat drug-resistant bacteria, the first to reach the market in nearly three decades. The new molecule, called ...

The Food and Drug Administration (FDA) recently approved a new antibiotic to treat urinary tract infections (UTIs). The drug gepotidacin, which will be sold under the brand name Blujepa, is approved ...

The small-molecule drug is the first in a new class of oral antibiotics for uUTIs ... who were randomized to gepotidacin or nitrofurantoin, which inhibits bacterial RNA, DNA and protein synthesis.

Alongside our introduction of a novel antibiotic class for the pathogen driving the second leading cause of cancer-related deaths, (31) iterative rounds of optimization inside REAL Space possess far ...

Researchers believe they have identified a new class of antibiotics, nearly three decades since the last new one came to market. Teams at McMaster University in Ontario, Canada and the University ...

For the first time in three decades, researchers believe they have identified a new class of antibiotics. Teams at McMaster University in Ontario, Canada and the University of Illinois ...

He says that to find new drugs to combat growing antimicrobial resistance, scientists must “look to more unusual or overlooked sources of antibiotics ... of this class of peptides.” ...

Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years ... In these studies, Blujepa was compared with nitrofurantoin, a leading treatment for uncomplicated UTIs.